Research progress on the mechanism of traditional Chinese insects' medicine treatment of diabetic neurological complications

doi:10.12092/j.issn.1009-2501.2018.05.019

Abstract

Abstract:

The therapeutic effect of traditional Chinese insects' medicine treatment for diabetic neurological complications is clear,and fruitful achievements in the study of mechanism of pharmacology have been down in recent years,including metabolism,immunity,and gene level.In this paper,the traditional Chinese insects' medicine treatment of diabetic neurological complications was summarized for the further study of traditional Chinese medicine targets.

Key words: diabetes mellitus, traditional Chinese insects' medicine treatment, neurological complication, clinical and experimental study

CLC Number:

R285.1

XU Ming, SHEN Zheng. Research progress on the mechanism of traditional Chinese insects' medicine treatment of diabetic neurological complications[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(5): 597-600.

References

［1］吕仁和.糖尿病及其并发症中西医诊治学［M］//.吕仁和,赵进喜,主编,糖尿病常见合并症.3版.北京:人民卫生出版社,2017:306-354.
［2］徐子涵, 蔡辉. 《临证指南医案》痹病辨治特点试析［J］. 中国中医基础医学杂志, 2017, 23(3):311-312.
［3］温昌明, 王新凯, 张保朝. 搜剔祛风、化瘀通络论治中风后遗症43例［J］. 中国实验方剂学杂志, 2014, 20(12):217-221.
［4］Selvarajah D, Wilkinson ID, Maxwell M, et al. Magnetic resonance neuroimaging study of brain structural differences in diabetic peripheral neuropathy［J］. Diabetes Care, 2014, 37(6):1681-1688.
［5］Malone JI. Diabetic central neuropathy: CNS damage related to hyperglycemia［J］. Diabetes, 2016, 65(2):355.
［6］潘永昕. 虫类药物在脑病治疗中的应用思路［J］. 中药药理与临床, 2015,31(2):239-240.
［7］崔雅忠, 李伏容, 张孟仁. 脑复聪方治疗肾虚血瘀型轻度认知功能障碍患者16例临床观察［J］. 中医杂志, 2015, 56(18):1577-1580.
［8］张孟仁, 张梅, 景光婵. 脑复聪对STZ-DM大鼠认知功能及海马NF-κB、星型胶质细胞的影响［J］. 中华中医药学刊, 2014,32(8):1991-1994.
［9］So K, Haraguchi K, Asakura K, et al. Involvement of TRPM2 in a wide range of inflammatory and neuropathic pain mouse models［J］. J Pharmacol Sci, 2015, 127(3):237-243.
［10］景光婵, 张孟仁. TRPM2在高糖活化小胶质细胞中的作用及脑复聪的干预研究［J］. 北京中医药, 2016,35(9):828-830.
［11］谢金锁. 脑心通胶囊联合奥扎格雷钠治疗糖尿病合并脑梗塞的疗效观察［J］. 临床医药文献电子杂志, 2016, 3(12):2422-2422.
［12］蒋伟. 脑心通改善2型糖尿病患者轻度认知功能的疗效分析［J］. 世界临床医学, 2016, 10(20):100.
［13］殷盛明, 赵丹, 于德钦,等. 蝎毒耐热肽对6羟多巴早期帕金森病大鼠的神经保护作用［J］. 生理学报, 2014, 66(6):658-666.
［14］刘炜,谭献文,彭晓青,等. 疏血通注射液对慢性脑缺血大鼠的保护机制实验研究［J］. 广州医药, 2013, 44(6):48-49.
［15］任瑞鲜,侯俊秀.疏血通注射液联合依达拉奉注射液治疗2型糖尿病伴急性脑梗死的疗效观察［J］.中西医结合心脑血管病杂志,2016,14(18):2186-2187.
［16］许岚. 糖尿病神经病变的诊断和治疗［J］. 泸州医学院学报, 2017, 40(1):14-18.
［17］张宏, 刘美奇, 王旭昀,等. 200例糖尿病周围神经病变患者中医证候调查分析［J］. 长春中医药大学学报, 2015, 31(1):99-101.
［18］方朝晖, 吴以岭, 赵进东. 糖尿病周围神经病变中医临床诊疗指南(2016年版)［J］. 中医杂志, 2017, 58(7):625-630.
［19］陆施婷, 陈清光, 徐佩英,等. 基于中医传承辅助平台探讨丁学屏名中医诊治糖尿病周围神经病变的临证经验及用药规律［J］. 辽宁中医杂志, 2017,44(7):1359-1363.
［20］张薇薇. 步长脑心通联合西药治疗糖尿病周围神经病变随机平行对照研究［J］. 实用中医内科杂志, 2015, 29(11):102-104.
［21］杨红. 虫类药物治疗糖尿病周围神经病变的临床研究［J］. 中国中医药科技, 2015, 22(1):17-18.
［22］吴亚楠, 梁晓春, 杨丹,等. 中药筋脉通对糖尿病大鼠背根神经节硝基酪氨酸和神经生长因子表达的影响［J］. 中国医学科学院学报, 2016, 38(5):507-513.
［23］吴群励, 张宏, 朴元林,等. 筋脉通胶囊通过增强背根神经节Nrf2和HO-1的表达改善糖尿病大鼠的周围神经痛［J］. 基础医学与临床, 2014, 34(2):179-184.
［24］王超, 张会欣, 邢邯英,等. 通心络胶囊对糖尿病周围神经病变模型小鼠炎症因子的影响［J］. 中国药房, 2015, 26(19):2621-2624.
［25］冯程程, 马丽. 温通活血乳膏对糖尿病周围神经病变大鼠氧化应激相关因子的影响［J］. 中华中医药杂志, 2017,32(3):1068-1072.
［26］Jun JE, Jin SM, Baek J, et al. The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes［J］. Cardiovasc Diabetol, 2015, 14(1):70.
［27］Ge X, Chen H, Zhang K, et al. The analysis of blood pressure profiles and their severity in relation to diabetic cardiovascular autonomic neuropathy in the Chinese population: preliminary analysis［J］. J Endocrinol Invest, 2016, 39(8):891-898.
［28］林海青, 杨金龙, 姚晓东,等. 糖尿病大鼠心脏自主神经损伤中神经营养因子的变化及桂枝汤的治疗作用［J］. 中西医结合心脑血管病杂志, 2015, 13(8): 979-982.
［29］Xu L,Li Z,Guo F.Curcumin improves expression of ghrelin through attenuating oxidative stress in gastric tissues of streptozotocin-induced diabetic gastroparesis rats［J］.Eur J Pharmacol,2013,718(1-3):219-225.
［30］窦家聪, 徐莉, 柏道明,等. 土鳖虫酶解液DA201-C不同洗脱部位溶栓活性药效学筛选［J］. 辽宁中医药大学学报, 2016,18(1):50-52.
［31］刘岩, 韩易言, 郑曲. 参松养心胶囊治疗糖尿病心脏自主神经病变随机平行对照研究［J］. 实用中医内科杂志, 2014,28(3):50-51.
［32］刘海立, 连书光. 参松养心胶囊治疗2型糖尿病心率变异性降低的研究现状［J］. 中医临床研究, 2016, 8(15):73-75.
［33］陈世健, 胡建华, 刘韬. 参松养心胶囊对糖尿病大鼠心室电生理特性及结构功能变化的影响［J］. 中国病理生理杂志, 2014, 30(8):1439-1444.
［34］王飞, 郭沛然, 韩菲,等. 益气养阴化瘀通络中药对糖尿病胃轻瘫大鼠平滑肌细胞凋亡的影响［J］. 世界华人消化杂志, 2014,22(13):1848-1853.
［35］王立业. 活血化瘀通络方对糖尿病胃轻瘫大鼠模型胃动素、胃泌素指标的影响研究［J］. 临床和实验医学杂志, 2016, 15(22):2188-2191.
［36］Zeid AA, Baher W, Zeid AA, et al. The neuroprotective effect of bee venom against diabetic neuropathy in a rat model: Ultrastructure and morphometric study［J］. Eur J Pharm Med Res, 2017, 4(8):50-59.

[1]	MA Yan, TIAN Gaopeng, SHI Xingwen, SUN Ting, XIE Jingjing, ZHEN Donghu. Correlation between 25(OH)D and metabolically related fatty liver in T2DM population [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1018-1026.
[2]	HOU Ruiying, GUO Lige, JIAO Weijie, DU Lei, WU Guiyue, ZHAO Xu. Effects of Xiaokeshu recipe on levels of serum inflammatory factors in type2 diabetic rats and its mechanism [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 377-382.
[3]	ZHAI Weiwei, YU Qiaoling, LIU Ping, QIU Bo, WU Huizhen. Research progress of finerenone in the treatment of type 2 diabetes mellitus complicated with chronic kidney disease [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 1067-1074.
[4]	LU Senlin, LIU Xinyuan, WANG Jili, HUANG Xiaofei. Research progress of virus-mediated gene therapy in type 2 diabetes mellitu [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 800-807.
[5]	DAI Hongyu, YANG Kun, HU Ruchun, ZHOU Hongmei, MA Peimin, HAO Qian. Duration time and effectiveness of 0.25%ropivacaine for sciatic nerve block in patients with diabetes [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1278-1284.
[6]	WU Yi, FANG Fang, CHEN Ying, Fan Junwei. Influence of donor and recipient CYP3A5 genotype on tacrolimus trough concentrations in the early stage after liver transplantation and its clinical significance [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 631-639.
[7]	XU Yongxia, XIE Mingzhu, GONG Muxue, HUANG Jiaying, ZHAO Li, ZHU Defa. Effects of 25(OH)D on islet β-cells function in the elderly with type 2 diabetes [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1021-1026.
[8]	ZHAO Hailing, ZHANG Haojun, ZHAO Tingting, YAN Meihua, DONG Xi, MA Liang, LI Ping. Association between the polymorphism of PNPLA2 gene and the risk of ischemic stroke in type 2 diabetic patients in Chinese Han Population [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 664-669.
[9]	HUANG Hao, XIAO Fang, JIA Hong, WANG Xiaoshuang, DUAN Yating. miR-138-5p protects β cell function by regulating HIF-1α in gestational diabetes mellitus [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 489-497.
[10]	YE Shengkai, WEN Jie, LIU Weiping, REN Xia, CHEN Haiying, DU Ying, LI Xue, ZHANG Ru, YU Li, ZHANG Biying. Effects of dapagliflozin on intima-medial thickness of carotid artery in type 2 diabetic mellitus patients [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(7): 814-819.
[11]	LI Zhuqing, JU Yinghui, CHEN Qingqing, MA Keke, LI Weiping. Protective effects of Astragaloside Ⅳ on early kidney damage in diabetes mellitus rats and its mechanisms [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(3): 255-262.
[12]	ZHANG Chunyan, FAN Xiaodong, QIN Yuan, KONG Wenqiang, ZHOU Chunyang, DU Biao. Markov model to assess long-term effects of teneligliptin in treatment of type 2 diabetes mellitus [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(1): 65-72.
[13]	SONG Meiqing. Effect of metformin on bone mineral density, insulin resistance and cytokines in type 2 diabetes mellitus patients with primary hypertension [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(6): 694-698.
[14]	LIU Chang, JIANG Daoli, LIU Xiaofang, XU Jia, WANG Lijue, WANG Qian, XU Ling, FANG Yi. Establishment of rat model of type 2 diabetes induced by streptozotocin combined with cerebral ischemic reperfusion injury [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(5): 518-525.
[15]	NI Yingqun, XIE Fengtao, FANG Zhaohui. Danzhijiangtang capsule protects vasculopathy of T2DM: an evaluation based on the expression of Wnt/β-catenin [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(5): 531-537.